BE719263A - - Google Patents

Info

Publication number
BE719263A
BE719263A BE719263DA BE719263A BE 719263 A BE719263 A BE 719263A BE 719263D A BE719263D A BE 719263DA BE 719263 A BE719263 A BE 719263A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE719263A publication Critical patent/BE719263A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Loading And Unloading Of Fuel Tanks Or Ships (AREA)
BE719263D 1967-08-12 1968-08-09 BE719263A (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB37136/67A GB1176194A (en) 1967-08-12 1967-08-12 Pharmaceutical Compositions

Publications (1)

Publication Number Publication Date
BE719263A true BE719263A (https=) 1969-02-10

Family

ID=10394029

Family Applications (1)

Application Number Title Priority Date Filing Date
BE719263D BE719263A (https=) 1967-08-12 1968-08-09

Country Status (19)

Country Link
US (1) US3665073A (https=)
JP (1) JPS4823889B1 (https=)
AT (1) AT288592B (https=)
BE (1) BE719263A (https=)
CA (1) CA920949A (https=)
CS (1) CS159232B2 (https=)
CY (1) CY681A (https=)
DE (1) DE1792233B1 (https=)
DK (1) DK123141B (https=)
ES (1) ES357071A1 (https=)
FI (1) FI48974C (https=)
FR (1) FR7751M (https=)
GB (1) GB1176194A (https=)
IE (1) IE32264B1 (https=)
IL (1) IL30529A (https=)
MY (1) MY7300271A (https=)
NL (1) NL6811233A (https=)
NO (1) NO128308B (https=)
SE (1) SE376548B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3762266A (en) * 1970-11-09 1973-10-02 Gould Inc Bimetal fastener
US3947572A (en) * 1974-07-01 1976-03-30 Abbott Laboratories Iron-resin adsorbate
US4015599A (en) * 1975-07-21 1977-04-05 Rohm And Haas Company Anesthetic delivery system
JPS64734U (https=) * 1987-06-20 1989-01-05
SE9103110D0 (sv) 1991-10-24 1991-10-24 Kabi Pharmacia Ab New drug formulation
US6495154B1 (en) 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
US20030099711A1 (en) * 2001-08-29 2003-05-29 David Meadows Sustained release preparations
PL206780B1 (pl) * 2001-10-17 2010-09-30 Minrad Inc Układ do podawania gazu pacjentowi
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
US10213437B2 (en) 2014-05-08 2019-02-26 Ctc Bio, Inc. Pharmaceutical preparation for masked taste oral administration, containing clomipramine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH383552A (de) * 1958-10-24 1964-10-31 Clinical Products Limited Verfahren zur Herstellung von Harz-Arzneistoffverbindungen
US3138525A (en) * 1961-06-16 1964-06-23 Hoffmann La Roche Castor wax-amprotropine-resin compositions
US3140978A (en) * 1961-11-02 1964-07-14 Hoffmann La Roche Pharmaceutical composition containing complex magnesium aluminum silicate
US3337402A (en) * 1963-09-03 1967-08-22 Hoffmann La Roche Stable and palatable pharmaceutical composition

Also Published As

Publication number Publication date
IE32264L (en) 1969-02-12
JPS4823889B1 (https=) 1973-07-17
ES357071A1 (es) 1970-02-16
DK123141B (da) 1972-05-23
GB1176194A (en) 1970-01-01
CA920949A (en) 1973-02-13
CS159232B2 (https=) 1974-12-27
US3665073A (en) 1972-05-23
IL30529A (en) 1972-04-27
DE1792233B1 (de) 1971-10-07
SE376548B (https=) 1975-06-02
FR7751M (https=) 1970-03-16
NL6811233A (https=) 1969-02-14
IL30529A0 (en) 1968-10-24
MY7300271A (en) 1973-12-31
AT288592B (de) 1971-03-10
FI48974C (fi) 1975-03-10
NO128308B (https=) 1973-10-29
CY681A (en) 1973-04-26
IE32264B1 (en) 1973-05-30
FI48974B (https=) 1974-12-02

Similar Documents

Publication Publication Date Title
FI48974B (https=)
BE699464A (https=)
BE709427A (https=)
BE709236A (https=)
BE709235A (https=)
BE708983A (https=)
BE708935A (https=)
BE708875A (https=)
BE708869A (https=)
BE708486A (https=)
BE708405A (https=)
BE708184A (https=)
BE708150A (https=)
BE708105A (https=)
BE708082A (https=)
BE707891A (https=)
BE707682A (https=)
BE707676A (https=)
BE711493A (https=)
BE707269A (https=)
BE711137A (https=)
BE710347A (https=)
BE709865A (https=)
BE709571A (https=)
BE706872A (https=)